Related Experiment Video
Updated: Jun 19, 2026
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
Biological evaluation of polymeric micelles with covalently bound doxorubicin
David Vetvicka1, Martin Hruby, Ondrej Hovorka
1Institute of Microbiology AS CR, v.v.i., Videnska 1083, 14220 Prague 4, Czech Republic. vetvicka@biomed.cas.cz
Abstract:
The main limitation of contemporary anticancer chemotherapy remains to be the insufficient specificity of the drugs for tumor tissue, which decreases the maximum tolerated dose due to severe side effects. Micellar drug delivery systems based on amphiphilic block copolymers with a very narrow size distribution (10 to 100 nm in diameter) is a novel innovative approach. Here, we report biological and pharmacological properties of polymeric micellar conjugate containing doxorubicin (DOX) covalently bound via hydrolytically cleavable hydrazone bonds to the micelle core. The system had a very low systemic toxicity (almost 20 times lower than free DOX) and long circulation in the bloodstream (with half of the dose after 24 h). Significant accumulation of tested micelles within the tumor was confirmed by fluorescent whole body imaging. Our new micellar system showed promising therapeutic activity against established murine EL-4 T-cell lymphoma; it was found that it is able to completely cure about 75% of tumor-bearing mice (with doses of either 1 x 150 mg DOX kg(-1) or 2 x 75 mg DOX kg(-1), administered i.v.). Moreover, treatment with micelles in cured mice induced tumor-specific resistance. Up to 80% of these mice survived rechallenge with original but not with distinct tumor cells.
Insights
This study introduces a novel micellar drug delivery system for doxorubicin (DOX) chemotherapy. The system significantly reduces toxicity and enhances therapeutic efficacy, leading to complete tumor remission in mice and inducing long-term tumor-specific resistance.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Conventional chemotherapy faces limitations due to poor drug specificity for tumor tissues, leading to severe side effects and reduced maximum tolerated doses.
- Polymeric micellar drug delivery systems offer an innovative approach to enhance drug targeting and reduce toxicity.
- Amphiphilic block copolymers enable the formation of micelles with controlled size (10-100 nm) for efficient drug encapsulation.
Purpose of the Study:
- To evaluate the biological and pharmacological properties of a novel micellar conjugate containing doxorubicin (DOX).
- To assess the in vivo toxicity, pharmacokinetics, tumor accumulation, and therapeutic efficacy of the DOX-loaded micelles.
- To investigate the potential for induced tumor-specific resistance following treatment with the micellar system.
Main Methods:
- Development of a polymeric micellar conjugate with doxorubicin (DOX) covalently bound via hydrolytically cleavable hydrazone bonds.
- Assessment of systemic toxicity and blood circulation time in vivo.
- In vivo tumor targeting was confirmed using fluorescent whole-body imaging.
- Evaluation of therapeutic activity against murine EL-4 T-cell lymphoma and assessment of tumor-specific resistance through rechallenge experiments.
Main Results:
- The micellar system exhibited significantly lower systemic toxicity compared to free DOX (approximately 20-fold reduction).
- The conjugate demonstrated prolonged circulation in the bloodstream, with a half-life allowing for sustained drug release.
- Fluorescent imaging confirmed substantial accumulation of micelles within the tumor tissue.
- Complete tumor remission was achieved in approximately 75% of tumor-bearing mice treated with the DOX micelles.
- Treated mice developed tumor-specific resistance, with 80% surviving rechallenge with the original tumor cells.
Conclusions:
- The developed polymeric micellar conjugate represents a promising advancement in targeted cancer chemotherapy.
- This novel system effectively reduces drug toxicity, enhances tumor accumulation, and achieves significant therapeutic outcomes.
- The induced tumor-specific resistance suggests potential for long-term protective immunity against cancer recurrence.
More Related Videos
10:53Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions
Published on: October 10, 2016
07:32Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
